Cargando…

Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia

Phosphatidylinositol-3-kinase (PI3K) pathway hyperactivation has been associated with the development of cancer and treatment resistance. PI3K inhibitors are now used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2−), PIK3CA-mutated advanced breast c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goncalves, Marcus D., Farooki, Azeez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793384/ https://www.ncbi.nlm.nih.gov/pubmed/35075945 http://dx.doi.org/10.1177/15347354211073163

Ejemplares similares

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
por: Brana, Irene, et al.
Publicado: (2012)

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
por: Zhao, Wennan, et al.
Publicado: (2017)

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
por: Fang, Xiaosheng, et al.
Publicado: (2013)

Sodium-Glucose Cotransporter-2 Inhibitors for Hyperglycemia in Phosphoinositide 3-kinase Pathway Inhibition
por: Weintraub, Michael A, et al.
Publicado: (2023)

Refractory hypercalcemia of malignancy: a problem with many potential roots
por: Farooki, Azeez
Publicado: (2023)

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
por: Lo, Wen-Ting, et al.
Publicado: (2022)

Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
por: Shey, Susan, et al.
Publicado: (2021)

Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHL
por: Forcello, Nicholas, et al.
Publicado: (2014)

Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
por: Starzyk, Tory, et al.
Publicado: (2021)

Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
por: Castillo, Jorge J, et al.
Publicado: (2014)

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
por: Wanigasooriya, Kasun, et al.
Publicado: (2020)

Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking
por: Yoshioka, Kazuaki
Publicado: (2021)

Purine analogs as phosphatidylinositol 4-kinase IIIβ inhibitors
por: Šála, Michal, et al.
Publicado: (2016)

Regulation of the Target of Rapamycin and Other Phosphatidylinositol 3-Kinase-Related Kinases by Membrane Targeting
por: De Cicco, Maristella, et al.
Publicado: (2015)

Treating breast cancer through novel inhibitors of the phosphatidylinositol 3'-kinase pathway
por: Crowder, Robert J, et al.
Publicado: (2005)

Inhibitors of Phosphatidylinositol 3′-Kinases Promote Mitotic Cell Death in HeLa Cells
por: Hou, Heli, et al.
Publicado: (2012)

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
por: Nelson, Elizabeth A., et al.
Publicado: (2017)

Efficacy of Phosphatidylinositol-3 Kinase Inhibitors in a Primary Mouse Model of Undifferentiated Pleomorphic Sarcoma
por: Kim, Suzy, et al.
Publicado: (2012)

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management
por: Girotra, Monica, et al.
Publicado: (2018)

Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
por: Shaker, Mohamed E., et al.
Publicado: (2023)

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells
Publicado: (1995)

The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer
por: Chu, Chien-An, et al.
Publicado: (2021)

The Role of Phosphatidylinositol Phosphate Kinases during Viral Infection
por: Beziau, Anne, et al.
Publicado: (2020)

Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms
por: Pandey, Ruchi, et al.
Publicado: (2015)

Phosphatidylinositol 3 kinase modulation of trophoblast cell differentiation
por: Kent, Lindsey N, et al.
Publicado: (2010)

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas
por: Cheson, Bruce D., et al.
Publicado: (2018)

Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013)

Role of Phosphatidylinositol-3-Kinase Pathway in Head and Neck Squamous Cell Carcinoma
por: Du, Li, et al.
Publicado: (2012)

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment
por: Liu, Dazhi, et al.
Publicado: (2022)

The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication
por: Delang, Leen, et al.
Publicado: (2012)

Architecture and dynamics of the autophagic phosphatidylinositol 3-kinase complex
por: Baskaran, Sulochanadevi, et al.
Publicado: (2014)

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
por: Cohen, Jeffrey I.
Publicado: (2018)

Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
por: Shaker, Mohamed E., et al.
Publicado: (2023)

In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells
por: Zhao, Wennan, et al.
Publicado: (2013)

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
por: LIN, LEHANG, et al.
Publicado: (2013)

Phosphatidylinositol 3-Kinase Is a Negative Regulator of Cellular Differentiation
por: Ptasznik, Andrzej, et al.
Publicado: (1997)

Impact of a Replacement Algorithm for Vitamin D Deficiency in Adult Hematopoietic Stem Cell Transplant Patients
por: Kenny, Sheila A., et al.
Publicado: (2019)

Multiple Phosphatidylinositol 3-Kinases Regulate Vaccinia Virus Morphogenesis
por: McNulty, Shannon, et al.
Publicado: (2010)

Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?
por: Tran, Phu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7rua9tgfo9avn9dkdf2hh79gl9